SR-4835, CAS [[2387704-62-1]]

Produktübersicht

• Artikelname: SR-4835, CAS [[2387704-62-1]]
• Artikelnummer: MCE-HY-130250
• Hersteller Artikelnummer: HY-130250
• Alternativnummer: MCE-HY-130250-100MG,MCE-HY-130250-10MG,MCE-HY-130250-10MMX1ML,MCE-HY-130250-500MG,MCE-HY-130250-25MG,MCE-HY-130250-50MG,MCE-HY-130250-5MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

SR-4835 is a potent, highly selective and ATP competitive dual inhibitor of CDK12/CDK13 (CDK12: IC50=99 nM, Kd=98 nM, CDK13: Kd=4.9 nM). SR-4835 acts in synergy with DNA-damaging chemotherapy and PARP inhibitors and provokes triple-negative breast cancer (TNBC) cell death[1].

Produkteigenschaften

• Molekulargewicht: 499.36
• Reinheit: 99.82
• CAS Nummer: [2387704-62-1]
• Formel: C21H20Cl2N10O
• Target-Kategorie: Apoptosis,CDK

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound